
Genotropin Enhances Muscle Mass and Strength in Sarcopenic American Males Over 65: A 2-Year RCT
Reading Time: 2 minutes Introduction Sarcopenia, the age-related loss of muscle mass and strength, significantly impacts the quality of life among older adults, particularly American males over the age of 65. This condition not only leads to reduced mobility and increased frailty but also heightens the risk of falls and fractures. In the quest for effective interventions, growth hormone therapy, specifically Genotropin, has emerged as a potential treatment. This article delves into the findings of a two-year randomized controlled trial that assessed the efficacy of Genotropin in treating sarcopenia in this demographic. Study Design and Methodology The study was meticulously designed as a randomized...